BLA Submission

---

Summary:   At Regal Intel, we understand the complexities and critical importance of Biologics License Applications (BLAs) for bringing life-saving and life-changing biological products to patients worldwide. Our expertise lies in guiding biotechnology and pharmaceutical companies through the rigorous regulatory landscape, ensuring comprehensive and compliant submissions across diverse global markets.

Successful BLA submission requires meticulous planning and execution, often necessitating a deep understanding of unique regional requirements. Regal Intel specializes in supporting global BLA strategies, providing unparalleled assistance for submissions to key regulatory bodies around the world, including:

• United States (US):  Food and Drug Administration (FDA)
• European Union (EU):  European Medicines Agency (EMA)
• Japan:  Pharmaceuticals and Medical Devices Agency (PMDA)
• Australia:  Therapeutic Goods Administration (TGA)
• Latin America:  Navigating regulations across countries like Brazil (ANVISA), Mexico (COFEPRIS), and others.
• China:  National Medical Products Administration (NMPA)
• Korea:  Ministry of Food and Drug Safety (MFDS)
• India:  Central Drugs Standard Control Organization (CDSCO)
• And other emerging markets as required.

Our team is adept at harmonizing regional differences, streamlining documentation, and anticipating regulatory challenges to facilitate efficient approval processes.

Regal Intel is your end-to-end partner throughout the entire product development lifecycle, extending beyond just BLA compilation. We are fully equipped to provide essential support where required for clinical trials, including:

• Clinical Trial Design & Protocol Development: Ensuring robust study designs that meet regulatory expectations and scientific objectives.
• Regulatory Submissions for Clinical Trials: Assisting with INDs (Investigational New Drug applications) and similar submissions to initiate clinical studies globally.
• Trial Management & Oversight: Providing expertise in project management,      vendor selection, and monitoring to ensure trials are conducted efficiently and compliantly.
• Data Analysis & Reporting: Supporting the compilation and interpretation of clinical data to fulfill BLA requirements.
• Quality Assurance & Compliance: Implementing stringent quality systems to ensure all clinical trial activities adhere to Good Clinical Practice (GCP) and relevant regulations.

Beyond clinical trials, our expertise covers critical BLA submission elements, ensuring every component is meticulously prepared:

• Technical Writing and Document Management: Our experienced technical writers specialize in transforming complex scientific and clinical data into clear, concise, and compliant regulatory documents. This includes:
  • Module 1: Administrative Information and Prescribing Information
  • Module 2: Summaries (e.g., Quality Overall Summary, Nonclinical Overview, Clinical Overview)
  • Module 3: Quality (Chemistry, Manufacturing, and Controls - CMC)
  • Module 4: Nonclinical Study Reports
  • Module 5: Clinical Study Reports
• Regulatory Strategy and Consulting: Providing guidance on optimal submission pathways, agency interactions, and addressing regulatory queries.
• Gap Analysis and Remediation: Identifying deficiencies in existing data or documentation and developing strategies to address them.
• eCTD Publishing: Ensuring all documents are correctly formatted and compiled into the electronic Common Technical Document (eCTD) structure for seamless submission to regulatory authorities.

Our integrated approach ensures that data generated from your clinical trials is meticulously prepared and presented, forming a strong foundation for your BLA submission, supported by expert technical documentation.

Choosing Regal Intel means partnering with a team dedicated to accelerating your biological product's journey to market. We offer:

• Deep Regulatory Expertise: Extensive knowledge of global BLA requirements and agency expectations.
• Strategic Global Reach: Proven ability to manage complex multi-country submissions.
• Integrated Solutions: Seamless support from clinical trial phases through to final BLA approval, including specialized technical documentation.
• Commitment to Excellence: A focus on quality, accuracy, and timely delivery to achieve your regulatory milestones.